The Supreme Court recently upheld the Affordable Care Act, under which HIV and AIDS are considered preexisting conditions, by a vote of 7 to 2.
For people living with HIV, not having the Affordable Care Act (ACA) would have limited their access to doctors and medications. There is no cure for HIV, so without the ACA, the disease would grow much more rapidly, stated Perry N. Halkitis, PhD, MS, MPH, dean, professor, and the director of the Center for Health, Identity Behavior & Prevention Studies at the Rutgers School of Public Health.
Transcript
What were the potential implications for persons living with HIV and AIDS had the ACA have been overturned?
The decision was monumental, right, because the 3 decisions, over the course of the last few years, it was 5 to 4 then 6 to 3 and 7 to 2, right? So, it looks pretty clear to me that the Supreme Court is going to uphold the Affordable Care Act, which is great, because health care access is a right. It’s a right.
So for people living with HIV, not having the Affordable Care Act and having [protections for] preexisting conditions would mean that one, they would have limited access to doctors, limited access to medications. We have no cure for HIV. I know people believe that HIV is over, but it's not over. We have 40,000 new infections each year, there's 1.2 million people in the United States who are living with HIV. Without the Affordable Care Act to actually allow people to see doctors and to be on medications, which is what keeps them healthy, the disease would grow much more rapidly.
The other thing we also know very clearly about HIV is that when people are diagnosed and they are on treatment, and they are virally suppressed, they cannot transmit the virus. And so the benefit of having people have access to medications is also for prevention of the spread of HIV. So, undetectable is untransmittable, it's something that we worked on for years, this slogan. So it would have been devastating to our effort to fight HIV.
Is there a part of me that feels like 40 years into the battle with HIV, we should have a vaccine? Of course we should. We have 4 for COVID-19. And one can't help but wonder the extent to which the federal government of the United States would have rallied to develop a vaccine and cures at a faster rate if it wasn't marginalized people who were affected by HIV.
If it wasn't gay men, if it wasn't Haitians, if it wasn't injection drug users. If it was the general population that was affected by [HIV], I wonder if the response would have been much more rapid. But I think there are a lot of activists out there who are thinking the same thing and who are, you know, a little angry about that.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora
March 26th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.
Read More